Targeting the “Undruggable” in Cancer Using Chemoproteomics-Enabled Covalent Ligand Discovery Platforms 2018 ASPIRE Award; 2020 ASPIRE II Award Daniel Nomura, PhD, University of California, Berkeley Read More
Abolishing Brachyury Function through Degradation 2018 Therapeutic Innovation Award, in partnership with Chordoma Foundation Craig Crews, PhD, Yale University Read More
Structure-Guided Drug Discovery for Brachyury Inhibitors 2018 Therapeutic Innovation Award, in partnership with Chordoma Foundation Opher Gileadi, PhD, University of Oxford; David Drewry, PhD, University of North Carolina; Charles Lin, PhD, Baylor College of Medicine Read More
A Model System for Robust Identification of Neoantigen-Specific T-Cell Receptors 2018 ASPIRE Award; 2020 ASPIRE II Award Michelle Krogsgaard, PhD (Principal); Jef Boeke, PhD; and Jeffrey Weber, MD, PhD, New York University Read More
The Polyethnic-1000 Project 2018 ASPIRE II Award David Tuveson, MD, PhD and Fieke Froeling, MD, PhD, Cold Spring Harbor Laboratory; Nicolas Robine, PhD, New York Genome Center Read More
The Mark Foundation Institute for Integrated Cancer Medicine The University of Cambridge, Cambridge UK Richard Gilbertson, MD; Jean Abraham, MD, PhD; James Brenton, MD, PhD; Kevin Brindle, PhD; Evis Sala, MD; Gregory Hannon, PhD; and Richard Samworth, PhD - Principal Investigators Read More
